Skip to content

Dynamic Humeral Centering in Impingement Syndrome

Assessment of Dynamic Humeral Centering in Impingement Syndrome: a Randomized Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01022775
Acronym
ADHCIS
Enrollment
70
Registered
2009-12-01
Start date
2001-04-30
Completion date
2007-02-28
Last updated
2009-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Rotator Cuff Disease With Impingement Syndrome

Keywords

Degenerative rotator cuff disease, Impingement syndrome, Dynamic humeral centering, Randomized clinical trial

Brief summary

The purpose of this study is to determine wether dynamic humeral centering is effective in patients with impingement syndrome of the shoulder

Detailed description

Clinical trial with randomization for treatment and physiotherapist

Interventions

PROCEDUREDynamic humeral centering

Dynamic humeral centering performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

PROCEDURENonspecific mobilisation

Nonspecific mobilisation performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

Sponsors

Societe Francaise de Rhumatologie
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
31 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 30 years * pain duration \> 1 month * presence of at least 2 positive impingement test results from Neer, Yocum and Hawkins testing * total Constant score \< 80.

Exclusion criteria

concerning the shoulder * stiffness * anteroposterior instability * tendinous calcification * corticosteroid injection within the previous 30 days * previous surgery * humeral fracture * inflammatory joint disease * neoplastic disorders

Design outcomes

Primary

MeasureTime frame
Constant total score as a mean and by categoryat 3 months

Secondary

MeasureTime frame
Constant total scoreat 12 months
Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) useat 3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026